The pharma major said it faces the largest drug-patent expiry headwind in its history this year.

Bausch Health and Lannett have settled a decadelong lawsuit regarding claims the drugmakers colluded to inflate generic drug prices, according to court documents filed in the U.S. District Court for ...

Novartis AG — with U.S. headquarters in North Jersey — drove up the price of 31 generic drugs through price fixing and bid ...

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

Tennessee reaches settlement with Lannett and Bausch over alleged drug price-fixing, addressing inflated costs for consumers and promoting fair competition.

Pennsylvania reached a $17.85 million settlement with two generic drug makers, the state’s attorney general said Monday. The companies, Lannett Company, Inc. and Bausch ...

"If we can't solve this problem, it's only a matter of time" before lives are lost ...

Arizona Attorney General Kris Mayes announced two settlements of more than $17.85 million with a pair of companies over ...

The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...

Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may ...

Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...

Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...